1
|
Stocker JT: Hepatoblastoma. Semin Diagn
Pathol. 11:136–143. 1994.PubMed/NCBI
|
2
|
Khaderi S, Guiteau J, Cotton RT, O'Mahony
C, Rana A and Goss JA: Role of liver transplantation in the
management of hepatoblastoma in the pediatric population. World J
Transplant. 4:294–298. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Hiyama E: Pediatric hepatoblastoma:
Diagnosis and treatment. Transl Pediatr. 3:293–299. 2014.PubMed/NCBI
|
4
|
Kayisli UA, Mahutte NG and Arici A:
Uterine chemokines in reproductive physiology and pathology. Am J
Reprod Immunol. 47:213–221. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Murdoch C and Finn A: Chemokine receptors
and their role in inflammation and infectious diseases. Blood.
95:3032–3043. 2000.PubMed/NCBI
|
6
|
Kollet O, Vagima Y, D'Uva G, Golan K,
Canaani J, Itkin T, Gur-Cohen S, Kalinkovich A, Caglio G, Medaglia
C, et al: Physiologic corticosterone oscillations regulate murine
hematopoietic stem/progenitor cell proliferation and CXCL12
expression by bone marrow stromal progenitors. Leukemia.
27:2006–2015. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Koch AE: Review: Angiogenesis:
Implications for rheumatoid arthritis. Arthritis Rheum. 41:951–962.
1998. View Article : Google Scholar : PubMed/NCBI
|
8
|
Selam B, Kayisli UA, Garcia-Velasco JA,
Akbas GE and Arici A: Regulation of fas ligand expression by IL-8
in human endometrium. J Clin Endocrinol Metab. 87:3921–3927. 2002.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Milliken D, Scotton C, Raju S, Balkwill F
and Wilson J: Analysis of chemokines and chemokine receptor
expression in ovarian cancer ascites. Clin Cancer Res.
84:1108–1114. 2002.
|
10
|
Arenberg DA, Keane MP, DiGiovine B, Kunkel
SL, Morris SB, Xue YY, Burdick MD, Glass MC, Iannettoni MD and
Strieter RM: Epithelial-neutrophil activating peptide (ENA-78) is
an important angiogenic factor in non-small cell lung cancer. J
Clin Invest. 102:465–472. 1998. View
Article : Google Scholar : PubMed/NCBI
|
11
|
Begley LA, MacDonald JW, Day ML and
Macoska JA: CXCL12 activates a robust transcriptional response in
human prostate epithelial cells. J Biol Chem. 282:26767–26774.
2007. View Article : Google Scholar : PubMed/NCBI
|
12
|
Murakami T, Maki W, Cardones AR, Fang H,
Kyi Tun A, Nestle FO and Hwang ST: Expression of CXC chemokine
receptor-4 enhances the pulmonary metastatic potential of murine
B16 melanomacells. Cancer Res. 15:7328–7334. 2002.
|
13
|
Hirbe AC, Morgan EA and Weilbaecher KN:
The CXCR4/SDF-1 chemokine axis: A potential therapeutic target for
bone metastases? Curr Pharm Des. 16:1284–1290. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Begley LA, Kasina S, Mehra R, Adsule S,
Admon AJ, Lonigro RJ, Chinnaiyan AM and Macoska JA: CXCL5 promotes
prostate cancer progression. Neoplasia. 10:244–254. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Miyazaki H, Patel V, Wang H, Edmunds RK,
Gutkind JS and Yeudall WA: Down-regulation of CXCL5 inhibits
squamous carcinogenesis. Cancer Res. 66:4279–4284. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Park JY, Park KH, Bang S, Kim MH, Lee JE,
Gang J, Koh SS and Song SY: CXCL5 overexpression is associated with
late stage gastric cancer. J Cancer Res Clin Oncol. 133:835–840.
2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH,
Wang Z, Huang XW, Fan J and Zhou J: Overexpression of CXCL5
mediates neutrophil infiltration and indicates poor prognosis for
hepatocellular carcinoma. Hepatology. 56:2242–2254. 2012.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Wang W, Li Y, Li Y, Hong A, Wang J, Lin B
and Li R: NDRG3 is an androgen regulated and prostate enriched gene
that promotes in vitro and in vivo prostate cancer cell growth. Int
J Cancer. 124:521–530. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rollins BJ: Inflammatory chemokines in
cancer growth and progression. Eur J Cancer. 42:760–767. 2006.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Speetjens FM, Kuppen PJ, Sandel MH, Menon
AG, Burg D, van de Velde CJ, Tollenaar RA, de Bont HJ and
Nagelkerke JF: Disrupted expression of CXCL5 in Colorectal cancer
is associated with rapid tumor formation in rats and poor prognosis
in patients. Clin Cancer Res. 14:2276–2284. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Xia J, Xu X, Huang P, He M and Wang X: The
potential of CXCL5 as a target for liver cancer - what do we know
so far? Expert Opin Ther Targets. 19:141–146. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
23
|
Yumnam S, Hong GE, Raha S, Saralamma VV,
Lee HJ, Lee WS, Kim EH and Kim GS: Mitochondrial dysfunction and
Ca(2+) overload contributes to hesperidin induced paraptosis in
hepatoblastoma cells, HepG2. J Cell Physiol. 231:1261–1268. 2016.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Nishikawa T, Tanaka Y, Nishikawa M, Ogino
Y, Kusamori K, Mizuno N, Mizukami Y, Shimizu K, Konishi S,
Takahashi Y and Takakura Y: Optimization of albumin secretion and
metabolic activity of cytochrome P450 1A1 of human hepatoblastoma
HepG2 cells in multicellular spheroids by controlling spheroid
size. Biol Pharm Bull. 40:334–338. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Leibowitz B and Yu J: Mitochondrial
signaling in cell death via the Bcl-2 family. Cancer Biol Ther.
9:417–422. 2010. View Article : Google Scholar : PubMed/NCBI
|
26
|
Khodapasand E, Jafarzadeh N, Farrokhi F,
Kamalidehghan B and Houshmand M: Is Bax/Bcl-2 ratio considered as a
prognostic marker with age and tumor location in colorectal cancer?
Iran Biomed J. 19:69–75. 2015.PubMed/NCBI
|
27
|
Zeren T, Inan S, Vatansever HS and Sayhan
S: Significance of apoptosis related proteins on malignant
transformation of ovarian tumors: A comparison between Bcl-2/Bax
ratio and p53 immunoreactiviy. Acta Histochem. 116:1251–1258. 2014.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Lee WS, Yi SM, Yun JW, Jung JH, Kim DH,
Kim HJ, Chang SH, Kim G, Ryu CH, Shin SC, et al: Polyphenols
isolated from allium cepa L. Induces apoptosis by induction of p53
and suppression of Bcl-2 through inhibiting PI3K/Akt signaling
pathway in AGS human cancer cells. J Cancer Prev. 19:14–22. 2014.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhang J, Li F, Liu X, Shen L, Liu J, Su J,
Zhang W, Deng Y, Wang L, Liu N, et al: The repression of human
differentiation-related gene NDRG2 expression by Myc via
Miz-1-dependent interaction with the NDRG2 core promoter. J Biol
Chem. 281:39159–39168. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhao W, Tang R, Huang Y, Wang W, Zhou Z,
Gu S, Dai J, Ying K, Xie Y and Mao Y: Cloning and expression
pattern of the human NDRG3 gene. Biochim Biophys Acta.
1519:134–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
31
|
Tian X, Meng L, Shou C and Dong Z:
Coexpression of vascular endothelial growth factor and its receptor
KDR on gastric adenocarcinoma MGC803 cell line and stimulation of
exogenous VEGF (165) to MGC803 cells. Sci China C Life Sci.
43:88–95. 2000. View Article : Google Scholar : PubMed/NCBI
|
32
|
Wu D, Si W, Wang M, Lv S, Ji A and Li Y:
Hydrogen sulfide in cancer: Friend or foe? Nitric Oxide. 50:38–45.
2015. View Article : Google Scholar : PubMed/NCBI
|
33
|
Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y,
Li N, Qi J, Wang L, Shi Y, et al: Sp1 is involved inregulation of
cystathionine γ-lyase gene expression and biological function by
PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell
Signal. 24:1229–1240. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Wang XH, Wang F, You SJ, Cao YJ, Cao LD,
Han Q, Liu CF and Hu LF: Dysregulation of cystathionine γ-lyase
(CSE)/hydrogen sulfide pathway contributes to ox-LDL-induced
inflammation in macrophage. Cell Signal. 25:2255–2262. 2013.
View Article : Google Scholar : PubMed/NCBI
|
35
|
Fan K, Li N, Qi J, Yin P, Zhao C, Wang L,
Li Z and Zha X: Wnt/β-catenin signaling induces the transcription
of cystathionine-γ-lyase, a stimulator of tumor in colon cancer.
Cell Signal. 26:2801–2808. 2014. View Article : Google Scholar : PubMed/NCBI
|
36
|
Palma G, Barbieri A, Bimonte S, Palla M,
Zappavigna S, Caraglia M, Ascierto PA, Ciliberto G and Arra C:
Interleukin 18: Friend or foe in cancer. Biochim Biophys Acta.
1836:296–303. 2013.PubMed/NCBI
|
37
|
Tu S, Bhagat G, Cui G, Takaishi S,
Kurt-Jones EA, Rickman B, Betz KS, Penz-Oesterreicher M, Bjorkdahl
O, Fox JG and Wang TC: Overexpression of interleukin-1beta induces
gastric inflammation and cancer and mobilizes
myeloid-derivedsuppressor cells in mice. Cancer Cell. 14:408–419.
2008. View Article : Google Scholar : PubMed/NCBI
|